Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2026 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
The Food and Drug Administration granted accelerated approval to the Tibotec Therapeutics protease inhibitor Prezista in June. When taken with a 100-milligram booster dose of Norvir, the drug is approved to treat drug-resistant virus. The FDA has required Boehringer Ingelheim to include a new black-box label warning for protease inhibitor Aptivus to warn of possible intracranial hemorrhages. The company reports that 13 patients taking Aptivus developed bleeding in the brain; eight died. The FDA has approved Gardasil, Merck's cervical cancer vaccine. It prevents infection with four strains of the sexually transmitted human papillomavirus linked to 70% of cervical cancers, which is an AIDS-defining illness in HIV-positive women. A study published in the Journal of Acquired Immune Deficiency Syndromes has shown that GlaxoSmithKline's protease inhibitor Lexiva can be safely used simultaneously with the heartburn pill Nexium. Prior studies had warned against mixing protease inhibitors with acid-lowering treatments. Independent Forensics has announced the development of the CCR5 Halotype Test, which determines human genetic resistance to HIV and helps gauge if a person will experience fast, average, or slow HIV disease progression. The test measures the number of CCR5 receptors on the surface of immune system cells; the more receptors, the faster HIV disease will progress.
From our Sponsors
Most Popular
The road to U=U: How science has been liberating HIV+ people for a decade
July 01 2026 12:05 PM
Newly diagnosed with HIV? Advocates share their best advice for seeking treatment
April 29 2026 3:32 PM
How to find an HIV-competent healthcare provider, according to advocates
May 19 2026 4:55 PM
Plus: Featured Video
Latest Stories
A New Once-Daily Pill to Treat HIV Just Got the FDA’s Green Light
August 31 2026 2:31 PM
Why affirming faith communities belong in the fight to end HIV
August 30 2026 8:00 AM
Navigating a new HIV diagnosis? Advocates say community is key
August 25 2026 3:33 PM
Gay Wine Weekend toasts 15 years of raising funds for HIV
August 25 2026 11:00 AM
A new HIV diagnosis doesn't have to be nerve-wracking. Advocates share their advice
July 30 2026 12:01 PM
Zero HIV Stigma Day: The epidemic we still choose to ignore
July 21 2026 7:00 AM
National HIV Prevention Day: Awareness is my superpower
July 17 2026 8:00 AM
Federal court clarifies that people with HIV can join the military again
June 03 2026 5:36 PM
Can a single infusion of immune cells suppress HIV for years?
May 11 2026 11:39 AM
National HIV advocacy group's CEO rejects claims of crisis
April 21 2026 5:14 PM
Beyond awareness: How youth leadership is reshaping the HIV response
April 10 2026 9:12 AM
Saving public health? AIDS United's new CEO has a plan
March 23 2026 9:48 AM
Struggling with daily HIV meds? Monthly shots may be the answer
March 20 2026 7:12 AM
Trending stories
Recommended Stories for You

































































